These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20850365)

  • 61. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.
    Michalská D; Stepan JJ; Basson BR; Pavo I
    J Clin Endocrinol Metab; 2006 Mar; 91(3):870-7. PubMed ID: 16352692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography.
    Kanis JA; Johnell O; Oden A; De Laet C; de Terlizzi F
    Osteoporos Int; 2005 Sep; 16(9):1065-70. PubMed ID: 15586268
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.
    Oleksik AM; Ewing S; Shen W; van Schoor NM; Lips P
    Osteoporos Int; 2005 Aug; 16(8):861-70. PubMed ID: 15558238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of raloxifene on bone turnover markers and bone mineral density in women on maintenance hemodialysis.
    Saito O; Saito T; Asakura S; Sugase T; Ito C; Ando Y; Muto S; Kusano E
    Clin Exp Nephrol; 2011 Feb; 15(1):126-31. PubMed ID: 21069410
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Raloxifene enhances vertebral mechanical properties independent of bone density.
    Allen MR; Iwata K; Sato M; Burr DB
    Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
    Howell A; Ashcroft L; Fallowfield L; Eccles DM; Eeles RA; Ward A; Brentnall AR; Dowsett M; Cuzick JM; Greenhalgh R; Boggis C; Motion J; Sergeant JC; Adams J; Evans DG
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):58-66. PubMed ID: 29097444
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics.
    Trontelj J; Marc J; Zavratnik A; Bogataj M; Mrhar A
    Br J Clin Pharmacol; 2009 Apr; 67(4):437-44. PubMed ID: 19371317
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preventive effects of raloxifene treatment on agerelated weight loss in postmenopausal women.
    Urano T; Shiraki M; Kuroda T; Tanaka S; Uenishi K; Inoue S
    J Bone Miner Metab; 2017 Jan; 35(1):108-113. PubMed ID: 26754796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis.
    Lu HF; Chou PH; Lin GH; Chou WH; Wang ST; Adikusuma W; Mugiyanto E; Hung KS; Chang WC
    Dis Markers; 2020; 2020():8855423. PubMed ID: 32934756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The effect of raloxifene on bone tissue in postmenopausal women].
    Kopeć M; Kucharz EJ
    Pol Arch Med Wewn; 2001 Dec; 106(6):1175-9. PubMed ID: 12026538
    [No Abstract]   [Full Text] [Related]  

  • 72. Re: Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance.
    Hamaya E; Sowa H
    Menopause; 2014 Jan; 21(1):109-10. PubMed ID: 24281238
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of raloxifene on bone metabolism in hemodialysis patients with type 2 diabetes.
    Saito O; Saito T; Asakura S; Akimoto T; Inoue M; Ando Y; Muto S; Kusano E
    Int J Endocrinol Metab; 2012; 10(2):464-9. PubMed ID: 23843805
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In reply.
    Urushihara H
    Menopause; 2014 Jan; 21(1):110. PubMed ID: 24326283
    [No Abstract]   [Full Text] [Related]  

  • 75. Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.
    Cosman F; Keaveny TM; Kopperdahl D; Wermers RA; Wan X; Krohn KD; Krege JH
    J Bone Miner Res; 2013 Jun; 28(6):1328-36. PubMed ID: 23281041
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.
    Paggiosi MA; Peel N; McCloskey E; Walsh JS; Eastell R
    Osteoporos Int; 2014 Dec; 25(12):2729-41. PubMed ID: 25074351
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene.
    Trdan Lušin T; Stieger B; Marc J; Mrhar A; Trontelj J; Zavratnik A; Ostanek B
    J Transl Med; 2012 Apr; 10():76. PubMed ID: 22533838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heel ultrasound can assess maintenance of bone mass in women with breast cancer.
    Langmann GA; Vujevich KT; Medich D; Miller ME; Perera S; Greenspan SL
    J Clin Densitom; 2012; 15(3):290-4. PubMed ID: 22425507
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Performance of quantitative ultrasound measurements of bone for monitoring raloxifene therapy.
    Paggiosi MA; Clowes JA; Finigan J; Naylor KE; Peel NF; Eastell R
    J Clin Densitom; 2010; 13(4):441-50. PubMed ID: 20850365
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria.
    Frost ML; Blake GM; Fogelman I
    Osteoporos Int; 1999; 10(6):441-9. PubMed ID: 10663343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.